BOSTON--(BUSINESS WIRE)--July 22, 2005--The Medicines and Healthcare products Regulatory Agency (MHRA) of the UK has signed a license with Lincoln Technologies, Inc. for the installation of Lincoln’s WebVDME pharmacovigilance signal detection and signal management software at MHRA. Lincoln was selected through a competitive procurement process that included extensive pilot testing of Lincoln’s tools by MHRA staff. This software acquisition is a component of a multi-year activity managed by Accenture to modernize the Agency’s IT systems. A key area of business system development within the Accenture-MHRA engagement is the Sentinel program, which will encourage open sharing of information across the Agency. The Pharmacovigilance Project will expand Sentinel core functionality to receive, process, record and analyze adverse reaction information, detect and assess signals and subsequently report on the data to interested parties.
